Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use
NCT07926880, Not applicable, Recruiting, Wayne State University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use | ClinicalTrials.gov |
| NCT number | NCT07926880 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 86 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Wayne State University | ClinicalTrials.gov |
| Conditions | Heavy Drinking, Alcohol Drinking | ClinicalTrials.gov |
| Interventions | Brief Motivational Intervention, SDT-Informed Letter-Writing Task, Neutral Writing Task | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Recruitment Feasibility: Enrollment Rate Among Eligible Individuals Who Accept an Invitation | From accepting the invitation to the Zoom session (up to 21 days) | Percentage of eligible people who accept an invitation and then enroll (attend the Zoom session, consent, and begin the baseline survey). | ClinicalTrials.gov |
| Primary | Session Completion Rate | Day 1 | Percentage of enrolled participants who complete all parts of the Zoom session. | ClinicalTrials.gov |
| Primary | Letter Completion Rate | Day 1 | Percentage of participants assigned to letter writing who complete a letter during the session. | ClinicalTrials.gov |
| Primary | Acceptability of the Letter-Writing Task (Acceptability of Intervention Measure) | Day 1 | Mean of 4 Acceptability of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater acceptability. Letter-writing participants only. | ClinicalTrials.gov |
| Primary | Appropriateness of the Letter-Writing Task (Intervention Appropriateness Measure) | Day 1 | Mean of 4 Intervention Appropriateness Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater appropriateness. Letter-writing participants only. | ClinicalTrials.gov |
| Primary | Feasibility of the Letter-Writing Task (Feasibility of Intervention Measure) | Day 1 | Mean of 4 Feasibility of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater feasibility. Letter-writing participants only. | ClinicalTrials.gov |
| Secondary | Retention at One-Month Follow-Up | Days 30 to 44 after the Zoom session | Proportion of randomized participants who complete the one-month follow-up survey within the 14-day response window (days 30-44 after the session), overall and by arm. | ClinicalTrials.gov |
| Secondary | State Autonomy for Drinking Decisions | Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session | Single item rated 1 (not at all) to 7 (completely); higher scores mean greater autonomy. | ClinicalTrials.gov |
| Secondary | State Competence for Reducing Drinking | Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session | Single item rated 1 (not capable at all) to 7 (extremely capable); higher scores mean greater competence. | ClinicalTrials.gov |
| Secondary | State Relatedness | Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session | Single item rated 1 (not at all connected) to 7 (extremely connected); higher scores mean greater relatedness. | ClinicalTrials.gov |
| Secondary | Perceived Competence for Reducing Alcohol Use (Perceived Competence Scale) | Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session | Mean of 4 items rated 1 (not at all true) to 7 (very true); higher scores mean greater perceived competence. | ClinicalTrials.gov |
| Secondary | Autonomous Motivation to Reduce Alcohol Use (Treatment Self-Regulation Questionnaire) | Start of the Zoom session (baseline) and 1 month after the Zoom session | Autonomous motivation score (mean of items rated 1 to 7); higher scores mean more autonomous motivation. | ClinicalTrials.gov |
| Other | Heavy Drinking Days (Timeline Followback) | Start of the Zoom session (baseline) and 1 month after the Zoom session | Number of days in the past 30 with 5 or more (men) or 4 or more (women) standard drinks, measured with the Timeline Followback. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)